Chen Zhuofa, Li Weizhi, Choi Gihoon, Yang Xiaonan, Miao Jun, Cui Liwang, Guan Weihua
Department of Electrical Engineering, Pennsylvania State University, University Park, PA 16802, USA.
Department of Entomology, Pennsylvania State University, University Park, PA 16802, USA.
Sensors (Basel). 2016 Sep 29;16(10):1616. doi: 10.3390/s16101616.
Microfluidics-based drug-screening systems have enabled efficient and high-throughput drug screening, but their routine uses in ordinary labs are limited due to the complexity involved in device fabrication and system setup. In this work, we report an easy-to-use and low-cost arbitrarily accessible 3D microfluidic device that can be easily adopted by various labs to perform combinatorial assays for high-throughput drug screening. The device is capable of precisely performing automatic and simultaneous reagent loading and aliquoting tasks and performing multistep assays with arbitrary sequences. The device is not intended to compete with other microfluidic technologies regarding ultra-low reaction volume. Instead, its freedom from tubing or pumping systems and easy operation makes it an ideal platform for routine high-throughput drug screening outside traditional microfluidic labs. The functionality and quantitative reliability of the 3D microfluidic device were demonstrated with a histone acetyltransferase-based drug-screening assay using the recombinant GCN5 enzyme, benchmarked with a traditional microtiter plate-based method. This arbitrarily accessible, multistep capable, low-cost, and easy-to-use device can be widely adopted in various combinatorial assays beyond high-throughput drug screening.
基于微流控技术的药物筛选系统实现了高效且高通量的药物筛选,但由于设备制造和系统设置的复杂性,其在普通实验室的常规应用受到限制。在这项工作中,我们报告了一种易于使用且低成本的任意可访问3D微流控设备,各种实验室都可以轻松采用该设备进行高通量药物筛选的组合分析。该设备能够精确地自动同时进行试剂加载和分装任务,并以任意顺序执行多步分析。该设备并非旨在在超低反应体积方面与其他微流控技术竞争。相反,它无需管道或泵送系统且操作简便,使其成为传统微流控实验室之外进行常规高通量药物筛选的理想平台。使用重组GCN5酶,通过基于组蛋白乙酰转移酶的药物筛选分析,以传统的基于微量滴定板的方法为基准,证明了3D微流控设备的功能和定量可靠性。这种任意可访问、具备多步操作能力、低成本且易于使用的设备可广泛应用于高通量药物筛选之外的各种组合分析。